Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies

SAN FRANCISCO and SUZHOU, China, Dec. 4, 2025 /PRNewswire/ — Innovent Biologics (HKEX: 01801) today announced that the global strategic collaboration with Takeda (TSE:…